KR20230104119A - 사이클로덱스트린으로 심혈관 질환 치료 방법 - Google Patents

사이클로덱스트린으로 심혈관 질환 치료 방법 Download PDF

Info

Publication number
KR20230104119A
KR20230104119A KR1020237010388A KR20237010388A KR20230104119A KR 20230104119 A KR20230104119 A KR 20230104119A KR 1020237010388 A KR1020237010388 A KR 1020237010388A KR 20237010388 A KR20237010388 A KR 20237010388A KR 20230104119 A KR20230104119 A KR 20230104119A
Authority
KR
South Korea
Prior art keywords
therapeutically effective
amount
administration
cyclodextrin
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020237010388A
Other languages
English (en)
Korean (ko)
Inventor
다이애나 커윈
제이슨 캠
Original Assignee
베렌 테라퓨틱스 피.비.씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베렌 테라퓨틱스 피.비.씨. filed Critical 베렌 테라퓨틱스 피.비.씨.
Publication of KR20230104119A publication Critical patent/KR20230104119A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020237010388A 2020-08-27 2021-08-27 사이클로덱스트린으로 심혈관 질환 치료 방법 Withdrawn KR20230104119A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
US63/071,257 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (1)

Publication Number Publication Date
KR20230104119A true KR20230104119A (ko) 2023-07-07

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237010388A Withdrawn KR20230104119A (ko) 2020-08-27 2021-08-27 사이클로덱스트린으로 심혈관 질환 치료 방법

Country Status (14)

Country Link
US (2) US20240000826A1 (https=)
EP (1) EP4203974A4 (https=)
JP (1) JP2023543131A (https=)
KR (1) KR20230104119A (https=)
CN (1) CN116322644A (https=)
AU (1) AU2021331487A1 (https=)
CA (1) CA3189915A1 (https=)
CO (1) CO2023003656A2 (https=)
CR (1) CR20230135A (https=)
IL (1) IL300805A (https=)
JO (1) JOP20230043A1 (https=)
MX (1) MX2023002418A (https=)
PE (1) PE20231169A1 (https=)
WO (1) WO2022047249A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
CN104244956B (zh) * 2012-04-13 2020-04-17 L&F研究有限公司 使用环糊精的方法

Also Published As

Publication number Publication date
US20240000826A1 (en) 2024-01-04
CO2023003656A2 (es) 2023-08-09
WO2022047249A1 (en) 2022-03-03
CA3189915A1 (en) 2022-03-03
JOP20230043A1 (ar) 2023-02-27
MX2023002418A (es) 2023-07-11
JP2023543131A (ja) 2023-10-13
CN116322644A (zh) 2023-06-23
US20230091966A1 (en) 2023-03-23
IL300805A (en) 2023-04-01
AU2021331487A1 (en) 2023-03-16
CR20230135A (es) 2023-07-19
PE20231169A1 (es) 2023-07-26
EP4203974A4 (en) 2024-08-07
EP4203974A1 (en) 2023-07-05

Similar Documents

Publication Publication Date Title
CN112996562A (zh) 治疗阿尔茨海默病的方法
JP7835735B2 (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
US20240082242A1 (en) Combination therapies
KR20120138229A (ko) 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료
KR20230104119A (ko) 사이클로덱스트린으로 심혈관 질환 치료 방법
US20240398849A1 (en) Methods for the treatment of hypertriglyceridemia with cyclodextrins
US20230375576A1 (en) Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
US20230302042A1 (en) Methods for the prevention of cholesterol crystal embolization with cyclodextrins
CN116829000A (zh) 组合疗法
KR20100051653A (ko) 관동맥의 묘출능 개선제

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203